334 related articles for article (PubMed ID: 1971019)
1. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
Devlin T; Shoemaker WJ
J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
[TBL] [Abstract][Full Text] [Related]
2. Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine.
Quirion R; Pilapil C; Magnan J
Cell Mol Neurobiol; 1987 Sep; 7(3):303-7. PubMed ID: 2830975
[TBL] [Abstract][Full Text] [Related]
3. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma.
Zhang WM; Jin WQ; Wong TM
J Mol Cell Cardiol; 1996 Jul; 28(7):1547-54. PubMed ID: 8841942
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of kappa-opioid binding sites in rat and guinea-pig spinal cord.
Wood MS; Rodriguez FD; Traynor JR
Neuropharmacology; 1989 Oct; 28(10):1041-6. PubMed ID: 2572992
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
Tiberi M; Magnan J
Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
[TBL] [Abstract][Full Text] [Related]
6. Kappa opioid binding sites in the dog cerebral cortex and spinal cord.
Hunter JC; Birchmore B; Woodruff R; Hughes J
Neuroscience; 1989; 31(3):735-43. PubMed ID: 2556660
[TBL] [Abstract][Full Text] [Related]
7. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
8. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor.
Nock B; Giordano AL; Cicero TJ; O'Connor LH
J Pharmacol Exp Ther; 1990 Aug; 254(2):412-9. PubMed ID: 2166790
[TBL] [Abstract][Full Text] [Related]
9. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine.
Morris BJ; Herz A
Neuroscience; 1986 Nov; 19(3):839-46. PubMed ID: 3025770
[TBL] [Abstract][Full Text] [Related]
11. [3H]U69,593 binding in guinea-pig brain: comparison with [3H]ethylketazocine binding at the kappa-opioid sites.
Tiberi M; Payette P; Mongeau R; Magnan J
Can J Physiol Pharmacol; 1988 Nov; 66(11):1368-72. PubMed ID: 2853991
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
Tiberi M; Magnan J
Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
[TBL] [Abstract][Full Text] [Related]
13. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
[TBL] [Abstract][Full Text] [Related]
14. kappa-Opioid binding sites on a murine lymphoma cell line.
Bidlack JM; Saripalli LD; Lawrence DM
Eur J Pharmacol; 1992 Nov; 227(3):257-65. PubMed ID: 1335414
[TBL] [Abstract][Full Text] [Related]
15. Selective protection of benzomorphan binding sites against inactivation by N-ethylmaleimide. Evidence for kappa-opioid receptors in frog brain.
Zawilska J; Lajtha A; Borsodi A
J Neurochem; 1988 Sep; 51(3):736-9. PubMed ID: 2900875
[TBL] [Abstract][Full Text] [Related]
16. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes.
Richardson A; Demoliou-Mason C; Barnard EA
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10198-202. PubMed ID: 1332034
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
Tiberi M; Magnan J
Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
[TBL] [Abstract][Full Text] [Related]
18. [3H]U-69593 a highly selective ligand for the opioid kappa receptor.
Lahti RA; Mickelson MM; McCall JM; Von Voigtlander PF
Eur J Pharmacol; 1985 Feb; 109(2):281-4. PubMed ID: 2986999
[TBL] [Abstract][Full Text] [Related]
19. Evidence for kappa 1 opioid receptor multiplicity in the guinea pig cerebellum.
Kinouchi K; Pasternak GW
Eur J Pharmacol; 1991 Jun; 207(2):135-41. PubMed ID: 1679014
[TBL] [Abstract][Full Text] [Related]
20. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
